The New Yorker faced backlash for promoting an essay claiming a woman could be "kind of pregnant," sparking debate over ...
EMPAVELI-treated adolescents achieved a 75% relative reduction in proteinuria within 6 months versus placebo EMPAVELI is the only approved treatment for adolescents with C3G and primary IC-MPGN, based ...
Abu Dhabi (DoH) has launched the Abu Dhabi Programme for the Future of Reproductive Health and its roadmap to achieve its targets by 2030. This move reflects Abu Dhabi’s vision to establish itself as ...
Company receives third Breakthrough Therapy Designation for RASONQUE and fifth across its portfolio of RAS(ON) inhibitors, further highlighting its differentiated strategy for developing innovative me ...
A Northwestern Medicine study has uncovered a previously unknown signaling system that helps regulate heart growth during ...
A study by researchers at Columbia University Vagelos College of Physicians and Surgeons has found that new cutting-edge ...
INVO Fertility Inc. is a healthcare services fertility company, which is engaged in expanding access to assisted reproductive technology (ART) care to patients in need. The Company’s principal ...
A 54-year-old Greek woman has given birth to a baby girl from an embryo frozen for 22 years. The birth came months after ...
Frost & Sullivan officially unveils the 2026 Global Stem Cell Industry Development Blue Book, providing an in-depth analysis of the global stem cell industry. The report comprehensively examines the ...
September 8, 2026, 7:30 a.m. CEST – Transgene (Euronext Paris: TNG), a biotech company that designs and develops virus-based immunotherapies for the treatment of cancer, and ProBioGen, a leading ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results